Cargando…

Targeting Nrf2 Signaling to Combat Chemoresistance

Nuclear factor E2-related factor 2 (Nrf2) is a transcription factor that upregulates expression of a battery of genes to combat oxidative and electrophilic stress. Modification of Kelch-like ECH-associated protein 1 (Keap1) by reactive oxygen species stabilizes Nrf2 by escaping from degradation. Nrf...

Descripción completa

Detalles Bibliográficos
Autores principales: No, Jae Hong, Kim, Yong-Beom, Song, Yong Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Cancer Prevention 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204167/
https://www.ncbi.nlm.nih.gov/pubmed/25337579
http://dx.doi.org/10.15430/JCP.2014.19.2.111
_version_ 1782340513406386176
author No, Jae Hong
Kim, Yong-Beom
Song, Yong Sang
author_facet No, Jae Hong
Kim, Yong-Beom
Song, Yong Sang
author_sort No, Jae Hong
collection PubMed
description Nuclear factor E2-related factor 2 (Nrf2) is a transcription factor that upregulates expression of a battery of genes to combat oxidative and electrophilic stress. Modification of Kelch-like ECH-associated protein 1 (Keap1) by reactive oxygen species stabilizes Nrf2 by escaping from degradation. Nrf2 then binds to antioxidant response elements (AREs) on the promoter region of various genes. Activation of the Keap1-Nrf2-ARE pathway plays critical roles in the chemopreventive effect of various phytochemicals. However, Nrf2 can protect cancer cells from oxidative stress and promote cell proliferation. Moreover, recent studies reveal that activation of the Nrf2 pathway is critical for resistance to chemotherapeutic agents. The aim of this review is to provide a molecular basis for the use of Nrf2 inhibitors in overcoming chemoresistance.
format Online
Article
Text
id pubmed-4204167
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Korean Society of Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-42041672014-10-21 Targeting Nrf2 Signaling to Combat Chemoresistance No, Jae Hong Kim, Yong-Beom Song, Yong Sang J Cancer Prev Review Nuclear factor E2-related factor 2 (Nrf2) is a transcription factor that upregulates expression of a battery of genes to combat oxidative and electrophilic stress. Modification of Kelch-like ECH-associated protein 1 (Keap1) by reactive oxygen species stabilizes Nrf2 by escaping from degradation. Nrf2 then binds to antioxidant response elements (AREs) on the promoter region of various genes. Activation of the Keap1-Nrf2-ARE pathway plays critical roles in the chemopreventive effect of various phytochemicals. However, Nrf2 can protect cancer cells from oxidative stress and promote cell proliferation. Moreover, recent studies reveal that activation of the Nrf2 pathway is critical for resistance to chemotherapeutic agents. The aim of this review is to provide a molecular basis for the use of Nrf2 inhibitors in overcoming chemoresistance. Korean Society of Cancer Prevention 2014-06 /pmc/articles/PMC4204167/ /pubmed/25337579 http://dx.doi.org/10.15430/JCP.2014.19.2.111 Text en Copyright © 2014 Korean Society of Cancer Prevention This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
No, Jae Hong
Kim, Yong-Beom
Song, Yong Sang
Targeting Nrf2 Signaling to Combat Chemoresistance
title Targeting Nrf2 Signaling to Combat Chemoresistance
title_full Targeting Nrf2 Signaling to Combat Chemoresistance
title_fullStr Targeting Nrf2 Signaling to Combat Chemoresistance
title_full_unstemmed Targeting Nrf2 Signaling to Combat Chemoresistance
title_short Targeting Nrf2 Signaling to Combat Chemoresistance
title_sort targeting nrf2 signaling to combat chemoresistance
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204167/
https://www.ncbi.nlm.nih.gov/pubmed/25337579
http://dx.doi.org/10.15430/JCP.2014.19.2.111
work_keys_str_mv AT nojaehong targetingnrf2signalingtocombatchemoresistance
AT kimyongbeom targetingnrf2signalingtocombatchemoresistance
AT songyongsang targetingnrf2signalingtocombatchemoresistance